Gapping down
In reaction to earnings/guidance:
- HIMS -7.9%, TWI -2.9%, NKE -2.7%
Other news:
- IDRA -63.1% (announces results from ILLUMINATE-301 trial; primary endpoint of ORR was not met)
- SKLZ -7.2% (prices offering of 32 mln shares of common stock at $24.00 per share)
- ROAD -6% (prices secondary offering by selling shareholders of 2 mln shares of common stock at $31.25 per share)
- MAX -4.1% (prices secondary offering by selling shareholders of 7 mln shares of common stock at $46.00 per share)
- ARRY -3.7% (prices offering of 31,054,971 shares of common stock at $28.00 per share)
- CB -3% (Hartford Financial: Chubb (CB) confirms preliminary proposal for The Hartford (HIG))
- TXRH -2.3% (announces passing of founder/CEO)
- EXR -2.2% (prices offering of 1.6 mln shares of common stock for gross proceeds of $207.7 mln)
- SLDB -2% (prices offering of 21,739,131 shares of its common stock at $5.75 per share)
- VTVT -1.4% (initiates study exploring the effects of TTP399 on ketone body formation; also files for $250 mln stock offering)
- NBEV -1.3% (stock offering)
Analyst comments:
- KMB -1.3% (downgraded to Underweight from Neutral at JP Morgan)
- BX -0.9% (downgraded to Perform from Outperform at Oppenheimer)